{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:26:38Z","timestamp":1794119198846,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03536-5","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T08:54:17Z","timestamp":1743411257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis"],"prefix":"10.1186","volume":"27","author":[{"given":"Marta","family":"Calatroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2990-8620","authenticated-orcid":false,"given":"Matteo","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"De Liso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Reggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"3536_CR1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","volume":"15","author":"JJ Weening","year":"2004","unstructured":"Weening JJ, D\u2019Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15:241\u201350.","journal-title":"J Am Soc Nephrol"},{"key":"3536_CR2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","volume":"93","author":"IM Bajema","year":"2018","unstructured":"Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT, et al. Revision of the international society of nephrology\/renal pathology society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93:789\u201396.","journal-title":"Kidney Int"},{"key":"3536_CR3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/annrheumdis-2017-212732","volume":"77","author":"G Moroni","year":"2018","unstructured":"Moroni G, Vercelloni PG, Quaglini S, Gatto M, Gianfreda D, Sacchi L, et al. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis. 2018;77:1318\u201325.","journal-title":"Ann Rheum Dis"},{"key":"3536_CR4","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/art.39674","volume":"68","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, et al. A longitudinal analysis of outcomes of lupus nephritis in an international inception cohort using a multistate model approach. Arthritis Rheumatol. 2016;68:1932\u201344.","journal-title":"Arthritis Rheumatol"},{"key":"3536_CR5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","volume":"82","author":"R Cervera","year":"2003","unstructured":"Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine. 2003;82:299\u2013308.","journal-title":"Medicine"},{"key":"3536_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.ajkd.2019.10.017","volume":"76","author":"SV Parikh","year":"2020","unstructured":"Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76:265\u201381.","journal-title":"Am J Kidney Dis"},{"key":"3536_CR7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.34067\/KID.0005512021","volume":"3","author":"G Moroni","year":"2022","unstructured":"Moroni G, Porata G, Raffiotta F, Quaglini S, Frontini G, Sacchi L, et al. Beyond ISN\/RPS lupus nephritis classification: adding chronicity index to clinical variables predicts kidney survival. Kidney360. 2022;3:122\u201332.","journal-title":"Kidney360"},{"key":"3536_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11926-023-01109-6","volume":"25","author":"A Banos","year":"2023","unstructured":"Banos A, Bertsias G. Flares in lupus nephritis: risk factors and strategies for their prevention. Curr Rheumatol Rep. 2023;25:183\u201391.","journal-title":"Curr Rheumatol Rep"},{"key":"3536_CR9","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1038\/ki.1996.528","volume":"50","author":"G Moroni","year":"1996","unstructured":"Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C. Nephritic flares are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int. 1996;50:2047\u201353.","journal-title":"Kidney Int"},{"key":"3536_CR10","doi-asserted-by":"crossref","unstructured":"Gatto M, Frontini G, Calatroni M, Reggiani F, Depascale R, Cruciani C, et al. Effect of sustained clinical remission on the risk of lupus flares and impaired kidney function in patients with lupus nephritis. Kidney Int Rep. 2024;9(4):1047\u201356.","DOI":"10.1016\/j.ekir.2024.01.016"},{"key":"3536_CR11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrneph.2012.220","volume":"8","author":"B Sprangers","year":"2012","unstructured":"Sprangers B, Monahan M, Appel GB. Diagnosis and treatment of lupus nephritis flares\u2013an update. Nat Rev Nephrol. 2012;8:709\u201317.","journal-title":"Nat Rev Nephrol"},{"key":"3536_CR12","doi-asserted-by":"crossref","unstructured":"Ayano M, Horiuchi T. Complement as a biomarker for systemic lupus erythematosus. Biomolecules. 2023;13.","DOI":"10.3390\/biom13020367"},{"key":"3536_CR13","first-page":"210","volume":"5","author":"P Eggleton","year":"2014","unstructured":"Eggleton P, Ukoumunne OC, Cottrell I, Khan A, Maqsood S, Thornes J, et al. Autoantibodies against C1q as a diagnostic measure of lupus nephritis: systematic review and meta-analysis. J Clin Cell Immunol. 2014;5:210.","journal-title":"J Clin Cell Immunol"},{"key":"3536_CR14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"3536_CR15","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1515\/cclm-2015-0072","volume":"53","author":"F de Liso","year":"2015","unstructured":"de Liso F, Matinato C, Novembrino C, Radice A, Raffiotta F, Ronchi M, et al. Value of a commercial kit for detecting anti-C1q autoantibodies and correlation with immunological and clinical activity of lupus nephritis. Clin Chem Lab Med. 2015;53:1771\u20137.","journal-title":"Clin Chem Lab Med"},{"key":"3536_CR16","doi-asserted-by":"crossref","unstructured":"Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Cheung M, Jadoul M et al. Nomenclature for kidney function and disease: executive summary and glossary from a kidney disease: improving global outcomes (KDIGO) consensus conference. Kidney Dis (Basel). 2020;6:309\u201317.","DOI":"10.1159\/000509359"},{"key":"3536_CR17","doi-asserted-by":"crossref","unstructured":"Moroni G, Porata G, Raffiotta F, Frontini G, Calatroni M, Reggiani F et al. Predictors of increase in chronicity index and of kidney function impairment at repeat biopsy in lupus nephritis. Lupus Sci Med. 2022;9.","DOI":"10.1136\/lupus-2022-000721"},{"key":"3536_CR18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2022.02.022","volume":"80","author":"MK Saha","year":"2022","unstructured":"Saha MK, Massicotte-Azarniouch D, Reynolds ML, Mottl AK, Falk RJ, Jennette JC, et al. Glomerular hematuria and the utility of urine microscopy: a review. Am J Kidney Dis. 2022;80:383\u201392.","journal-title":"Am J Kidney Dis"},{"key":"3536_CR19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/0961203316669241","volume":"26","author":"MU Mart\u00ednez-Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez-Mart\u00ednez MU, Llamazares-Azuara LMDG, Mart\u00ednez-Galla D, Mandeville PB, Valadez-Castillo F, Rom\u00e1n-Acosta S, et al. Urinary sediment suggests lupus nephritis histology. Lupus. 2017;26:580\u20137.","journal-title":"Lupus"},{"key":"3536_CR20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10067-012-2017-1","volume":"31","author":"Z Chen","year":"2012","unstructured":"Chen Z, Wang GS, Wang GH, Li XP. Anti-C1q antibody is a valuable biological marker for prediction of renal pathological characteristics in lupus nephritis. Clin Rheumatol. 2012;31:1323\u20139.","journal-title":"Clin Rheumatol"},{"key":"3536_CR21","doi-asserted-by":"crossref","first-page":"106904","DOI":"10.1155\/2015\/106904","volume":"2015","author":"G Moroni","year":"2015","unstructured":"Moroni G, Quaglini S, Radice A, Trezzi B, Raffiotta F, Messa P, et al. The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy. J Immunol Res. 2015;2015:106904.","journal-title":"J Immunol Res"},{"key":"3536_CR22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0961203319829827","volume":"28","author":"K Ichinose","year":"2019","unstructured":"Ichinose K, Kitamura M, Sato S, Eguchi M, Okamoto M, Endo Y, et al. Complete renal response at 12 months after induction therapy is associated with renal relapse-free rate in lupus nephritis: a single-center, retrospective cohort study. Lupus. 2019;28:501\u20139.","journal-title":"Lupus"},{"key":"3536_CR23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/art.10142","volume":"46","author":"GG Illei","year":"2002","unstructured":"Illei GG, Takada K, Parkin D, Austin HA, Crane M, Yarboro CH, et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum. 2002;46:995\u20131002.","journal-title":"Arthritis Rheum"},{"key":"3536_CR24","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1046\/j.1523-1755.2002.00280.x","volume":"61","author":"M Mosca","year":"2002","unstructured":"Mosca M, Bencivelli W, Neri R, Pasquariello A, Batini V, Puccini R, et al. Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int. 2002;61:1502\u20139.","journal-title":"Kidney Int"},{"key":"3536_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0961203315606985","volume":"25","author":"JM Mej\u00eda-Vilet","year":"2016","unstructured":"Mej\u00eda-Vilet JM, C\u00f3rdova-S\u00e1nchez BM, Arreola-Guerra JM, Morales-Buenrostro LE, Uribe-Uribe NO, Correa-Rotter R. Renal flare prediction and prognosis in lupus nephritis hispanic patients. Lupus. 2016;25:315\u201324.","journal-title":"Lupus"},{"key":"3536_CR26","doi-asserted-by":"crossref","unstructured":"Kapsia E, Marinaki S, Michelakis I, Liapis G, Sfikakis PP, Boletis J et al. Predictors of early response, flares, and long-term adverse renal outcomes in proliferative lupus nephritis: a 100-month median follow-up of an inception cohort. J Clin Med. 2022;11.","DOI":"10.3390\/jcm11175017"},{"key":"3536_CR27","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/art.20364","volume":"50","author":"CC Mok","year":"2004","unstructured":"Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, et al. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. Arthritis Rheum. 2004;50:2559\u201368.","journal-title":"Arthritis Rheum"},{"key":"3536_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.55563\/clinexprheumatol\/c58c39","volume":"40","author":"G Ligtenberg","year":"2022","unstructured":"Ligtenberg G, Arends S, Stegeman CA, de Leeuw K. Predictors of renal flares and long-term renal outcome in patients with lupus nephritis: results from daily clinical practice. Clin Exp Rheumatol. 2022;40:33\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"3536_CR29","doi-asserted-by":"crossref","first-page":"e000123","DOI":"10.1136\/lupus-2015-000123","volume":"2","author":"F Tamirou","year":"2015","unstructured":"Tamirou F, Lauwerys BR, Dall\u2019Era M, Mackay M, Rovin B, Cervera R, et al. A proteinuria cut-off level of 0.7\u00a0g\/day after 12\u2005months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN nephritis trial. Lupus Sci Med. 2015;2:e000123.","journal-title":"Lupus Sci Med"},{"key":"3536_CR30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.39026","volume":"67","author":"M Dall\u2019Era","year":"2015","unstructured":"Dall\u2019Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, et al. Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus nephritis cohort. Arthritis Rheumatol. 2015;67:1305\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"3536_CR31","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1093\/rheumatology\/keaa129","volume":"59","author":"I Parodis","year":"2020","unstructured":"Parodis I, Adamichou C, Aydin S, Gomez A, Demoulin N, Weinmann-Menke J, et al. Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis. Rheumatology (Oxford). 2020;59:3424\u201334.","journal-title":"Rheumatology (Oxford)"},{"key":"3536_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","volume":"16","author":"C Ponticelli","year":"2017","unstructured":"Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Saf. 2017;16:411\u20139.","journal-title":"Expert Opin Drug Saf"},{"key":"3536_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/09612033211062515","volume":"31","author":"V Andrade Balbi","year":"2022","unstructured":"Andrade Balbi V, Artur Silva C, Nascimento Pedrosa T, Maria Rodrigues Pereira R, Maria de Arruda Campos L, Pires Leon E, et al. Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis. Lupus. 2022;31:97\u2013104.","journal-title":"Lupus"},{"key":"3536_CR34","first-page":"1604","volume":"33","author":"C Cunha","year":"2018","unstructured":"Cunha C, Alexander S, Ashby D, Lee J, Chusney G, Cairns TD, et al. Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome? Nephrol Dial Transpl. 2018;33:1604\u201310.","journal-title":"Nephrol Dial Transpl"},{"key":"3536_CR35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/rheumatology\/kead253","volume":"63","author":"A Gomez","year":"2024","unstructured":"Gomez A, J\u00e4gerback S, Sj\u00f6wall C, Parodis I. Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials. Rheumatology (Oxford). 2024;63:338\u201348.","journal-title":"Rheumatology (Oxford)"},{"key":"3536_CR36","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.2215\/CJN.04830421","volume":"16","author":"G Moroni","year":"2021","unstructured":"Moroni G, Frontini G, Ponticelli C. When and how is it possible to stop therapy in patients with lupus nephritis: a narrative review. Clin J Am Soc Nephrol. 2021;16:1909\u201317.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3536_CR37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/1319-2442.284008","volume":"31","author":"G Emad","year":"2020","unstructured":"Emad G, Al-Barshomy SM. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity. Saudi J Kidney Dis Transpl. 2020;31:342\u201352.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"3536_CR38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3899\/jrheum.090779","volume":"37","author":"X Cai","year":"2010","unstructured":"Cai X, Yang X, Lian F, Lin X, Liang M, Li J, et al. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. J Rheumatol. 2010;37:759\u201365.","journal-title":"J Rheumatol"},{"key":"3536_CR39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.03990415","volume":"11","author":"DJ Birmingham","year":"2016","unstructured":"Birmingham DJ, Bitter JE, Ndukwe EG, Dials S, Gullo TR, Conroy S, et al. Relationship of circulating anti-C3b and anti-C1q IgG to lupus nephritis and its flare. Clin J Am Soc Nephrol. 2016;11:47\u201353.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03536-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03536-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03536-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T04:41:09Z","timestamp":1743828069000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03536-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3536"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03536-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,31]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of IRCCS Humanitas Rozzano, Milano, Italy (protocol code NEF0032023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided informed consent for the scientific use of their anonymized data. Patient or public involvement in the research was not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}